Literature DB >> 1592018

Prevalence of epilepsy in adults in northern Sweden.

L Forsgren1.   

Abstract

A multisource medical register review identified persons with active epilepsy in northern Sweden. Seven hundred thirteen persons aged greater than or equal to 17 years with epilepsy were determined on the prevalence day, December 31, 1985. The overall prevalence was 553 in 100,000 (566 in 100,000 if adjusted to the 1980 U.S. population). The ratio of males to females was 1.1, with a male prevalence of 575 and a female prevalence of 530 in 100,000. Age-specific prevalences varied between 530-644 in 100,000 except in persons aged greater than or equal to 70 years, for whom the prevalence was 321 in 100,000. Partial seizures were most common, 333 in 100,000, of whom the majority (250 in 100,000) had seizures that occasionally were secondarily generalized. Mental retardation was the foremost coexistent disorder, noted in 23%. The mean yearly seizure frequency was higher in persons with mental retardation than in nonretarded persons. Seventeen percent had seizures during the last week, 57% during the last year, whereas 16% had greater than or equal to 5 years' freedom from seizures. Most had onset of epilepsy before age 20 years. A presumed etiology was noted in 35%, more often in men than in women. Cerebrovascular disease was the most commonly identified presumed cause. Other nonepileptic diseases/disabilities were noted in 47%.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1592018     DOI: 10.1111/j.1528-1157.1992.tb01690.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  16 in total

Review 1.  The descriptive epidemiology of epilepsy-a review.

Authors:  Poonam Nina Banerjee; David Filippi; W Allen Hauser
Journal:  Epilepsy Res       Date:  2009-04-15       Impact factor: 3.045

2.  Importance of genetic factors in the occurrence of epilepsy syndrome type: a twin study.

Authors:  Linda A Corey; John M Pellock; Marianne J Kjeldsen; Karl Otto Nakken
Journal:  Epilepsy Res       Date:  2011-08-31       Impact factor: 3.045

3.  Physical illness and disability among elderly people in England and Wales: the Medical Research Council Cognitive Function and Ageing Study. The Analysis Group.

Authors:  C J Parker; K Morgan; M E Dewey
Journal:  J Epidemiol Community Health       Date:  1997-10       Impact factor: 3.710

4.  Association of epilepsy and comorbid conditions.

Authors:  Michael Seidenberg; Dalin T Pulsipher; Bruce Hermann
Journal:  Future Neurol       Date:  2009-09-01

Review 5.  Seizures in alcohol-dependent patients: epidemiology, pathophysiology and management.

Authors:  Matti Hillbom; Ilkka Pieninkeroinen; Maurizio Leone
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 6.  Prevalence of Seizure/Epilepsy in Patients with Multiple Sclerosis: A Systematic Review and Meta-Analysis.

Authors:  Omid Mirmosayyeb; Vahid Shaygannejad; Nasim Nehzat; Aida Mohammadi; Mahsa Ghajarzadeh
Journal:  Int J Prev Med       Date:  2021-02-24

7.  Accounting for comorbidity in assessing the burden of epilepsy among US adults: results from the National Comorbidity Survey Replication (NCS-R).

Authors:  R C Kessler; M C Lane; V Shahly; P E Stang
Journal:  Mol Psychiatry       Date:  2011-05-17       Impact factor: 15.992

Review 8.  Epilepsy in India I: Epidemiology and public health.

Authors:  Senthil Amudhan; Gopalkrishna Gururaj; Parthasarathy Satishchandra
Journal:  Ann Indian Acad Neurol       Date:  2015 Jul-Sep       Impact factor: 1.383

9.  Clinical features of epilepsy at 2 referral hospitals in Northern Iran.

Authors:  Mahdi Rezaeian Yazdi; Morteza Mazloum Farsi Baf; Atena Afsari; Afrouz Alipour; Mostafa Khorashadizadeh; Peyman Khajeh Ghiassi; Seyed Mehran Homam
Journal:  Neurosciences (Riyadh)       Date:  2015-07       Impact factor: 0.906

10.  The economic burden of epilepsy in Korea, 2010.

Authors:  Jaehun Jung; Hye-Young Seo; Young Ae Kim; In-Hwan Oh; Yo Han Lee; Seok-Jun Yoon
Journal:  J Prev Med Public Health       Date:  2013-11-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.